Company: INDP
Filing Date: 2025-03-13
Form Type: 10-K
Source: 0001493152-25-010136
Chunk: 577

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-03-13
Form: 10-K
Item: Item 3
Chunk 577
---
 relate to accounts or disclosures that are material to the consolidated financial
statements and (2) involved our especially challenging, subjective, or complex judgments. We determined that there are no critical audit
matters.

    /s/
    Haskell & White LLP

    HASKELL
    & WHITE LLP

We
have served as the Company’s auditor since 2021.

Irvine,
California

March 13,
2025

F-2

INDAPTUS
THERAPEUTICS, INC.

Consolidated
Balance Sheets

    2024  
    2023 

    December 31, 

    2024  
    2023 
  
    Assets 

    Current assets: 

    Cash and cash equivalents 
    $5,786,753  
    $13,362,053 
  
    Prepaid expenses and other current assets 
     831,577  
     633,156 

    Total current assets 
     6,618,330  
     13,995,209 

    Non-current assets: 

    Property and equipment, net 
     -  
     735 
  
    Right-of-use asset 
     82,175  
     173,206 
  
    Other assets - deposits to third parties 
     638,251  
     754,728 

    Total non-current assets 
     720,426  
     928,669 

    Total assets 
    $7,338,756  
    $14,923,878 

    Liabilities and stockholders’ equity 

    Current liabilities: 

    Accounts payable and other current liabilities 
    $3,309,717  
    $2,672,327 
  
    Operating lease liability, current portion 
     84,164  
     101,705 

    Total current liabilities 
     3,393,881  
     2,774,032 

    Non-current liabilities: 

    Operating lease liability, net of current portion 
     -  
     73,348 

    Total non-current liabilities 
     -  
     73,348 

    Total liabilities 
     3,393,881  
     2,847,380 

    Commitments and contingencies (Note 7) 
     -  
     - 

    Stockholders’